About Continuus Pharma
Continuus Pharma is a company based in Woburn (United States) founded in 2012.. Continuus Pharma has raised $7.73 million across 7 funding rounds from investors including Industria Macchine Automatiche, Mark Bamforth and National Science Foundation. The company has 47 employees as of December 31, 2022. Continuus Pharma operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Woburn, United States
- Employees 47 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Continuus Pharmaceuticals
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.73 M (USD)
in 7 rounds
-
Latest Funding Round
$5 M (USD), Series B
Aug 26, 2019
-
Investors
Industria Macchine Automatiche
& 2 more
-
Employee Count
47
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Continuus Pharma
Continuus Pharma has successfully raised a total of $7.73M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series B — $5.0M
-
First Round
First Round
(21 May 2013)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2019 | Amount | Series B - Continuus Pharma | Valuation | Mark Bamforth | |
| Mar, 2016 | Amount | Grant - Continuus Pharma | Valuation |
investors |
|
| Feb, 2016 | Amount | Grant - Continuus Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Continuus Pharma
Continuus Pharma has secured backing from 3 investors, including angel and institutional investors. Prominent investors backing the company include Industria Macchine Automatiche, Mark Bamforth and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Automated packaging machinery is manufactured for multiple industries.
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location | |
|
MB
Mark Bamforth |
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Continuus Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Continuus Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Continuus Pharma Comparisons
Competitors of Continuus Pharma
Continuus Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| domain | founded_year | HQ Location |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| domain | founded_year | HQ Location |
APIs and finished products are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Continuus Pharma
Frequently Asked Questions about Continuus Pharma
When was Continuus Pharma founded?
Continuus Pharma was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Continuus Pharma located?
Continuus Pharma is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Is Continuus Pharma a funded company?
Continuus Pharma is a funded company, having raised a total of $7.73M across 7 funding rounds to date. The company's 1st funding round was a Grant of $1.26M, raised on May 21, 2013.
How many employees does Continuus Pharma have?
As of Dec 31, 2022, the latest employee count at Continuus Pharma is 47.
What does Continuus Pharma do?
Formed as a spinout company of the 65M collaboration between MIT and Novartis, Continuus Pharma offers one stop solutions for the development and manufacturing of continuous manufacturing solutions by removing the walls between API and FDF manufacturing. Their proprietary Integrated Continuous Manufacturing (ICM) technology for small molecule pharmaceuticals integrates the entire API and FDF manufacturing process into a continuous and seamless process and offers capabilities for on-demand manufacturing of pharmaceuticals and thus significant advantages w.r.t lead time, costs and quality. Apart from integrated solutions, they also offer targeted solutions for a wide range of unit operations such as a continuous reactor to handle solids in flow, membrane separator by-pass, heterogeneous crystallization, integrated nucleator and tubular crystallizers, continuous filtration, continuous dryer, extrusionforming and thin filmelectrospinning.
Who are the top competitors of Continuus Pharma?
Continuus Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Who are Continuus Pharma's investors?
Continuus Pharma has 3 investors. Key investors include Industria Macchine Automatiche, Mark Bamforth, and National Science Foundation.